Logo image of CXM

SPRINKLR INC-A (CXM) Stock Fundamental Analysis

NYSE:CXM - New York Stock Exchange, Inc. - US85208T1079 - Common Stock - Currency: USD

8.02  -0.03 (-0.37%)

After market: 8.02 0 (0%)

Fundamental Rating

5

Taking everything into account, CXM scores 5 out of 10 in our fundamental rating. CXM was compared to 284 industry peers in the Software industry. CXM has only an average score on both its financial health and profitability. CXM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
CXM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXM reported negative net income in multiple years.
CXM had a positive operating cash flow in 4 of the past 5 years.
CXM Yearly Net Income VS EBIT VS OCF VS FCFCXM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

CXM has a better Return On Assets (9.20%) than 85.92% of its industry peers.
CXM has a Return On Equity of 17.10%. This is amongst the best in the industry. CXM outperforms 84.51% of its industry peers.
CXM has a Return On Invested Capital of 4.36%. This is in the better half of the industry: CXM outperforms 74.30% of its industry peers.
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROIC 4.36%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
CXM Yearly ROA, ROE, ROICCXM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 13.58%, CXM belongs to the top of the industry, outperforming 80.99% of the companies in the same industry.
CXM has a Operating Margin of 4.42%. This is in the better half of the industry: CXM outperforms 71.48% of its industry peers.
CXM has a Gross Margin (71.05%) which is comparable to the rest of the industry.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
CXM Yearly Profit, Operating, Gross MarginsCXM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

CXM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CXM has been reduced compared to 1 year ago.
Compared to 5 years ago, CXM has more shares outstanding
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CXM Yearly Shares OutstandingCXM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXM Yearly Total Debt VS Total AssetsCXM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.66 indicates that CXM is not a great score, but indicates only limited risk for bankruptcy at the moment.
CXM has a Altman-Z score (2.66) which is in line with its industry peers.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.66
ROIC/WACC0.48
WACC9.02%
CXM Yearly LT Debt VS Equity VS FCFCXM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

CXM has a Current Ratio of 1.74. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.74, CXM perfoms like the industry average, outperforming 54.58% of the companies in the same industry.
CXM has a Quick Ratio of 1.74. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CXM (1.74) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
CXM Yearly Current Assets VS Current LiabilitesCXM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CXM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.52%.
The Revenue has been growing slightly by 6.75% in the past year.
Measured over the past years, CXM shows a quite strong growth in Revenue. The Revenue has been growing by 19.68% on average per year.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%

3.2 Future

The Earnings Per Share is expected to grow by 6.28% on average over the next years.
CXM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.56% yearly.
EPS Next Y14.83%
EPS Next 2Y11.94%
EPS Next 3Y11.75%
EPS Next 5Y6.28%
Revenue Next Year3.92%
Revenue Next 2Y4.36%
Revenue Next 3Y5.33%
Revenue Next 5Y8.56%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CXM Yearly Revenue VS EstimatesCXM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CXM Yearly EPS VS EstimatesCXM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.11 indicates a rather expensive valuation of CXM.
78.17% of the companies in the same industry are more expensive than CXM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.35, CXM is valued at the same level.
The Price/Forward Earnings ratio is 18.29, which indicates a rather expensive current valuation of CXM.
CXM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CXM is cheaper than 78.87% of the companies in the same industry.
CXM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 21.11
Fwd PE 18.29
CXM Price Earnings VS Forward Price EarningsCXM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CXM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXM is cheaper than 81.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXM is valued cheaper than 81.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20
EV/EBITDA 19.28
CXM Per share dataCXM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CXM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CXM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y11.94%
EPS Next 3Y11.75%

0

5. Dividend

5.1 Amount

CXM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (6/20/2025, 8:27:49 PM)

After market: 8.02 0 (0%)

8.02

-0.03 (-0.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-04 2025-06-04/bmo
Earnings (Next)09-02 2025-09-02/amc
Inst Owners79.44%
Inst Owner Change-0.67%
Ins Owners6.03%
Ins Owner Change47%
Market Cap2.07B
Analysts65.56
Price Target9.89 (23.32%)
Short Float %7.16%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.14%
Min EPS beat(2)21.24%
Max EPS beat(2)39.04%
EPS beat(4)3
Avg EPS beat(4)17.48%
Min EPS beat(4)-14.78%
Max EPS beat(4)39.04%
EPS beat(8)7
Avg EPS beat(8)34.7%
EPS beat(12)11
Avg EPS beat(12)104.49%
EPS beat(16)15
Avg EPS beat(16)86.72%
Revenue beat(2)1
Avg Revenue beat(2)0.39%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.8%
Revenue beat(4)3
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)1.16%
Revenue beat(8)6
Avg Revenue beat(8)1.02%
Revenue beat(12)9
Avg Revenue beat(12)0.95%
Revenue beat(16)13
Avg Revenue beat(16)1.74%
PT rev (1m)-5.75%
PT rev (3m)-8.71%
EPS NQ rev (1m)4.31%
EPS NQ rev (3m)9.69%
EPS NY rev (1m)4.11%
EPS NY rev (3m)5.75%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 21.11
Fwd PE 18.29
P/S 2.57
P/FCF 20
P/OCF 17.28
P/B 3.23
P/tB 3.51
EV/EBITDA 19.28
EPS(TTM)0.38
EY4.74%
EPS(NY)0.44
Fwd EY5.47%
FCF(TTM)0.4
FCFY5%
OCF(TTM)0.46
OCFY5.79%
SpS3.13
BVpS2.48
TBVpS2.29
PEG (NY)1.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROCE 5.13%
ROIC 4.36%
ROICexc 24.79%
ROICexgc 42.07%
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
FCFM 12.83%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 86.2%
Cap/Sales 2.02%
Interest Coverage 250
Cash Conversion 219.67%
Profit Quality 94.52%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 2.66
F-Score7
WACC9.02%
ROIC/WACC0.48
Cap/Depr(3y)122.21%
Cap/Depr(5y)126.89%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y14.83%
EPS Next 2Y11.94%
EPS Next 3Y11.75%
EPS Next 5Y6.28%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%
Revenue Next Year3.92%
Revenue Next 2Y4.36%
Revenue Next 3Y5.33%
Revenue Next 5Y8.56%
EBIT growth 1Y-16.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.65%
EBIT Next 3Y38.72%
EBIT Next 5Y27.79%
FCF growth 1Y241.27%
FCF growth 3YN/A
FCF growth 5Y33.79%
OCF growth 1Y148.61%
OCF growth 3YN/A
OCF growth 5Y32.54%